Multivalular Disease Management Suggestions for Trial Design

Sunday, March 8, 2026

2:24 PM - 2:32 PM EST

Location: International Ballroom East

Speaker(s)

Jeffrey J. Popma, MD

Chief Scientific Officer
CRF
Newton, Massachusetts, United States

Disclosure(s): Medtronic: CMO ended Nov 2024 (Terminated, November 1, 2024), Stock-publicly held company (excluding mutual/index funds) (Terminated, November 1, 2024)

Disclosure(s):

Jeffrey J. Popma, MD: Medtronic: CMO ended Nov 2024 (Terminated, November 1, 2024), Stock-publicly held company (excluding mutual/index funds) (Terminated, November 1, 2024)